New hope for kids with rare eye disease
NCT ID NCT07298928
Summary
This study is testing a medication called Telitacicept in children with ocular myasthenia gravis, a condition that causes eye muscle weakness. The goal is to see if this treatment can better control symptoms and reduce the need for steroids, which often cause side effects. Researchers will enroll 30 children under 18 who have this condition and are already on standard treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EFFECTIVENESS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Children's Hospital Affiliated to Shandong University
Jinan, Shandong, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Shenzhen children's Hospital of China Medical University
Shenzhen, Guangdong, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The Children's Hospital, Zhejiang University School of Medicine
Hangzhou, Zhejiang, 310052, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.